Amdocs Limited DOX

57.71 (0.65) (1.11%) as of 25 Sep
Market cap
$6.2B
P/E
13.7×
Growth Flags show if company had growth for consecutive years
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
12.95% 15.45% 16.08% 15.90%

+8 more TTM periods

ROA
6.98% 8.52% 8.87% 8.77%
ROIC
9.39% 10.68% 11.19% 11.63%
Return on Tangible Assets
71.01% 75.52% 67.72% 55.31%
Average Days of Receivables
79.20 74.08 76.75 75.35
Free Cash Flow per Share
6.17 6.47 6.99 5.92
Free Cash Flow
638.84 678.74 754.89 645.14
Capital Expenditures
(109.98) (114.11) (108.84) (103.95)
Piotroski F-Score
4.00 5.00 5.00 5.00
Other line items
Cash ROIC
16.33% 16.98% 18.66% 16.34%
Accounts Receivable Turnover
4.73 4.88 4.69 4.62
Accounts Payable Turnover
7.65 8.33 8.21 8.30
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
43.69 43.68 47.90 48.19
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.22) (0.20) (0.17) (0.18)
Research and Development Expense of Revenue
7.38% 7.44% 7.39% 7.52%
Selling, General and Administrative Expense of Revenue
11.57% 11.18% 10.87% 11.17%
Share Based Compensation of Revenue
2.37% 2.48% 2.24% 2.31%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.68 1.48 1.54 1.35
Depreciation/Fixed assets
0.28 0.28 0.27 0.26
Capex/Depreciation
(0.53) (0.56) (0.54) (0.53)
Revenue per Share
44.97 44.05 42.43 41.56
Operating CF per Share
7.24 7.56 8.00 6.87
Capex per Share
(1.06) (1.09) (1.01) (0.95)
Capex to Sales
0.02 0.02 0.02 0.02
Net Profit Margin
9.56% 11.58% 12.24% 12.22%

Fold the line items

Columns are period end dates